These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 378729)

  • 41. [Comparative effects of diltiazem and nifedipine combined with propranolol, in patients with chronic stable angina pectoris].
    Asenjo R; Corbalán R; Casanegra P; Chamorro G; Valenzuela P
    Rev Med Chil; 1987 Jun; 115(6):512-7. PubMed ID: 3331020
    [No Abstract]   [Full Text] [Related]  

  • 42. Oxprenolol and propranolol in anxiety states. A double-blind comparative study.
    Becker AL
    S Afr Med J; 1976 Apr; 50(16):627-9. PubMed ID: 772831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies with a slow-release formulation of propranolol in angina.
    McIlmoyle EL; Blair AL; Calvert HW; Boyle DM; Shanks RG; Leahey W; Barber JM
    Ir Med J; 1979 Jan; 72(1):27-8. PubMed ID: 365833
    [No Abstract]   [Full Text] [Related]  

  • 44. Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.
    Narahara KA
    Am J Cardiol; 1990 Mar; 65(9):577-82. PubMed ID: 2178381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Slow-Trasicor in the treatment of angina pectoris].
    Giec L; Trusz-Gluza M; Hübner D; Olwiński M
    Wiad Lek; 1984 Sep; 37(18):1401-6. PubMed ID: 6397916
    [No Abstract]   [Full Text] [Related]  

  • 46. Dose response effectiveness of propranolol for the treatment of angina pectoris.
    Alderman EL; Davies RO; Crowley JJ; Lopes MG; Brooker JZ; Friedman JP; Graham AF; Matlof HJ; Harrison DC
    Circulation; 1975 Jun; 51(6):964-75. PubMed ID: 805675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sotalol in angina pectoris. A double-blind study.
    Slome R
    S Afr Med J; 1976 Mar; 50(12):469-72. PubMed ID: 818720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study of the action of beta-adrenergic blockers in the treatment of angina pectoris].
    de Mey D
    Acta Cardiol; 1972; ():Suppl 15:255-6. PubMed ID: 4147609
    [No Abstract]   [Full Text] [Related]  

  • 50. Double-blind comparison of long acting propranolol and sustained release metoprolol in the treatment of angina pectoris.
    Irving JB; Edwards RE
    Br J Clin Pract; 1987 Aug; 41(8):872-5. PubMed ID: 3329528
    [No Abstract]   [Full Text] [Related]  

  • 51. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
    Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
    Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind, placebo-controlled trial of propranolol given once, twice and four times daily in stable angina pectoris: a multicenter study using serial exercise testing.
    Beller GA; Bittar N; Coelho JB; Craddock GB; Ezekowitz MD; Murray GC; Steen SN; Waksman JA
    Am J Cardiol; 1984 Jul; 54(1):37-42. PubMed ID: 6377865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propranolol in the treatment of angina: a review.
    Prichard BN
    Postgrad Med J; 1976; 52 Suppl 4():35-41. PubMed ID: 787954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol.
    Parker JO; Porter A; Parker JD
    Circulation; 1982 Jun; 65(7):1351-5. PubMed ID: 6804113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ST 567 compared with propranolol in stable angina.
    Ceremuzynski L; Nartowicz E; Dluzniewski M; Perkowicz J; Czarnecki W; Burduk P; Budaj A; Bednarz B; Chamiec T; Jurgiel R
    Eur Heart J; 1987 Dec; 8 Suppl L():159-63. PubMed ID: 3330528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B; Dahlqvist A; Raak A; Wrege U
    Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled clinical trial of propranolol alone and in combination with dilazep in patients with angina pectoris.
    Biswas NR; Pandhi P; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):241-4. PubMed ID: 2198233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectoris.
    Bassan MM; Weiler-Ravell D
    Am Heart J; 1983 Feb; 105(2):234-8. PubMed ID: 6823805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.